Casi Pharmaceuticals Inc (CASI)

Nov 19, 2025

How resilient is CASI Pharmaceuticals Inc. stock in market downturns2025 Key Lessons & Long-Term Capital Growth Strategies - newser.com

Nov 19, 2025

Nov 19, 2025

How CASI Pharmaceuticals Inc. stock performs in weak economyGap Up & Daily Growth Stock Tips - newser.com

Nov 19, 2025

Nov 19, 2025

How to read the order book for CASI Pharmaceuticals Inc.2025 Market Outlook & Weekly Top Gainers Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is CASI Pharmaceuticals Inc. stock gaining market shareJuly 2025 Trends & Growth Oriented Trade Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Is CASI Pharmaceuticals Inc. stock a top momentum playMarket Performance Summary & Weekly High Potential Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

CASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman - TipRanks

Nov 19, 2025

Nov 19, 2025

CASI Pharmaceuticals Announces Changes in Board Governance - Bluefield Daily Telegraph

Nov 19, 2025

Nov 19, 2025

CASI Pharmaceuticals (NASDAQ: CASI) appoints James Huang Non-Executive Chairman - Stock Titan

Nov 19, 2025

Nov 19, 2025

What MACD and RSI say about CASI Pharmaceuticals Inc.2025 Macro Impact & Fast Entry Momentum Alerts - newser.com

Nov 19, 2025

Nov 16, 2025

Smart tools for monitoring CASI Pharmaceuticals Inc.’s price actionTrade Analysis Summary & Safe Swing Trade Setups - newser.com

Nov 16, 2025

Nov 16, 2025

Is CASI Pharmaceuticals Inc. stock attractive for retirement portfoliosTrade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com

Nov 16, 2025

Nov 16, 2025

Can CASI Pharmaceuticals Inc. stock resist sector downturnsBuy Signal & Expert Approved Momentum Trade Ideas - newser.com

Nov 16, 2025

Nov 15, 2025

Will CASI Pharmaceuticals Inc. stock attract more institutional investorsChart Signals & Capital Protection Trade Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

CASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal - MSN

Nov 15, 2025

Nov 14, 2025

CASI Pharmaceuticals Stumbles On Revenue Drop And Nasdaq Challenge - Finimize

Nov 14, 2025

Nov 14, 2025

Casi Pharmaceuticals Q3 revenue drops 60%, net loss widens - MarketScreener

Nov 14, 2025

Nov 14, 2025

CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results - ACCESS Newswire

Nov 14, 2025

Nov 14, 2025

CASI Pharmaceuticals (NASDAQ: CASI) reports third-quarter revenue $3.1M; net loss $10.9M - Stock Titan

Nov 14, 2025

Nov 14, 2025

CASI Pharmaceuticals (CASI) Projected to Post Quarterly Earnings on Friday - Defense World

Nov 14, 2025

Nov 13, 2025

CASI Pharmaceuticals, Inc. (CASI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 13, 2025

Nov 11, 2025

CASI Pharmaceuticals Appeals Nasdaq Delisting Determination - MSN

Nov 11, 2025

Nov 10, 2025

CASI Pharmaceuticals faces Nasdaq delisting over market value requirement By Investing.com - Investing.com Nigeria

Nov 10, 2025

Nov 10, 2025

CASI Pharmaceuticals faces Nasdaq delisting over market value requirement - Investing.com

Nov 10, 2025

Nov 10, 2025

CASI Pharmaceuticals : Receives and Appeals Delisting Determination from NASDAQ - MarketScreener

Nov 10, 2025

Nov 10, 2025

[6-K] CASI Pharmaceuticals, Inc. Current Report (Foreign Issuer) | CASI SEC FilingForm 6-K - Stock Titan

Nov 10, 2025

Nov 10, 2025

CASI Pharmaceuticals appeals NASDAQ delisting determination - MSN

Nov 10, 2025